Stryker moved 0.1% this afternoon session, trading between a high of $294.2 and a low of $291.2 per share. Yesterday the stock finished at $293.22 per share, compared to an average analyst target price of $321.57.
Stryker Corporation operates as a medical technology company. The large-cap medical/dental instruments company is based in the United States, and over the last twelve months it has returned a dividend yield of 1.0%. Stryker has trailing twelve months earnings per share (EPS) of 7.09, which at today's prices amounts to a price to earnings (P/E) ratio of 41.4.
Based on its expected future earnings growth, the company has a price to earnings growth (PEG) ratio of 2.81. Usually a PEG ratio between 0 and 1 indicates a potentially undervalued company.
Overview of the Company's Gross Margins:
|Date Reported||Revenue ($ k)||Cost of Revenue ($ k)||Gross Margins (%)||YoY Growth (%)|
At 64.5%, Stryker's average gross margins are wider than the 57.74% average of its industry peer group, which suggests that the firm might have a competitive advantage.